Associate Professor Lydie Trautmann is researcher at the Vaccine and Gene Therapy Institute, Oregon Health and Science University.

She received her PhD in Immunology in 2003 and started working on HIV immunity in 2004. Her laboratory studies the cellular immune response in acute HIV infection, during ART and in therapeutic studies to define new strategies to induce HIV remission.

Associate Professor Lydie Trautmann co-leads DARE RF1, Objective 3 with Associate Professor Rachel Rutishauser.